Tammy Harutunyan, PharmD Candidate
Articles by Tammy Harutunyan, PharmD Candidate

Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.

Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma
ByAmin Zakkour Khudari, PharmD Candidate,Tammy Harutunyan, PharmD Candidate,Mohamad Zakour Khadari, MPharm,Rami Madani, MD Candidate,David S. Bateshansky, PharmD, BCOP,Amir Ali, PharmD, BCOP Pharmacists play a vital role in therapy selection.

The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis
ByJose Tinajero, PharmD, BCOP,Amir Ali, PharmD, BCOP,Tammy Harutunyan, PharmD Candidate,Teny Khachadourian, PharmD Candidate,Michaela Maher, PharmD Candidate The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.